Suppr超能文献

基于纳米羟基磷灰石/聚酰胺66支架的双肽缓释系统协同增强糖尿病大鼠骨折愈合中的成骨作用和血管生成

A Dual Peptide Sustained-Release System Based on Nanohydroxyapatite/Polyamide 66 Scaffold for Synergistic-Enhancing Diabetic Rats' Fracture Healing in Osteogenesis and Angiogenesis.

作者信息

Li Jian, Wei Jiaxing, Li Ang, Liu Hongyu, Sun Jingxue, Qiao Hong

机构信息

Department of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

出版信息

Front Bioeng Biotechnol. 2021 May 26;9:657699. doi: 10.3389/fbioe.2021.657699. eCollection 2021.

Abstract

Diabetes mellitus impairs fracture healing and function of stem cells related to bone regeneration; thus, effective bone tissue engineering therapies can intervene with those dysfunctions. Nanohydroxyapatite/polyamide 66 (n-HA/PA66) scaffold has been used in fracture healing, whereas the low bioactivity limits its further application. Herein, we developed a novel bone morphogenetic protein-2- (BMP-2) and vascular endothelial growth factor- (VEGF) derived peptides-decorated n-HA/PA66 (BVHP66) scaffold for diabetic fracture. The n-HA/PA66 scaffold was functionalized by covalent grafting of BMP-2 and VEGF peptides to construct a dual peptide sustained-release system. The structural characteristics and peptide release profiles of BVHP66 scaffold were tested by scanning electron microscopy, Fourier transform infrared spectroscopy, and fluorescence microscope. Under high glucose (HG) condition, the effect of BVHP66 scaffold on rat bone marrow mesenchymal stem cells' (rBMSCs) adherent, proliferative, and differentiate capacities and human umbilical vein endothelial cells' (HUVECs) proliferative and tube formation capacities was assessed. Finally, the BVHP66 scaffold was applied to fracture of diabetic rats, and its effect on osteogenesis and angiogenesis was evaluated. , the peptide loaded on the BVHP66 scaffold was in a sustained-release mode of 14 days. The BVHP66 scaffold significantly promoted rBMSCs' and HUVECs' proliferation and improved osteogenic differentiation of rBMSCs and tube formation of HUVECs in HG environment. , the BVHP66 scaffold enhanced osteogenesis and angiogenesis, rescuing the poor fracture healing in diabetic rats. Comparing with single peptide modification, the dual peptide-modified scaffold had a synergetic effect on bone regeneration . Overall, this study reported a novel BVHP66 scaffold with excellent biocompatibility and bioactive property and its application in diabetic fracture.

摘要

糖尿病会损害骨折愈合以及与骨再生相关的干细胞功能;因此,有效的骨组织工程疗法可以干预这些功能障碍。纳米羟基磷灰石/聚酰胺66(n-HA/PA66)支架已用于骨折愈合,但其低生物活性限制了其进一步应用。在此,我们开发了一种新型的用于糖尿病骨折的骨形态发生蛋白-2(BMP-2)和血管内皮生长因子(VEGF)衍生肽修饰的n-HA/PA66(BVHP66)支架。通过将BMP-2和VEGF肽共价接枝使n-HA/PA66支架功能化,构建双肽缓释系统。通过扫描电子显微镜、傅里叶变换红外光谱和荧光显微镜对BVHP66支架的结构特征和肽释放曲线进行了测试。在高糖(HG)条件下,评估了BVHP66支架对大鼠骨髓间充质干细胞(rBMSCs)的黏附、增殖和分化能力以及人脐静脉内皮细胞(HUVECs)的增殖和管形成能力的影响。最后,将BVHP66支架应用于糖尿病大鼠骨折,评估其对成骨和血管生成的影响。结果表明,负载在BVHP66支架上的肽以14天的缓释模式释放。BVHP66支架显著促进了rBMSCs和HUVECs的增殖,并改善了HG环境中rBMSCs的成骨分化和HUVECs的管形成。结果表明,BVHP66支架增强了成骨和血管生成,挽救了糖尿病大鼠骨折愈合不良的情况。与单肽修饰相比,双肽修饰支架对骨再生具有协同作用。总体而言,本研究报道了一种具有优异生物相容性和生物活性的新型BVHP66支架及其在糖尿病骨折中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d5/8188490/848679c34e62/fbioe-09-657699-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验